[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN116478126B - Preparation and application of A-D-A type organic micromolecular photosensitizer - Google Patents

Preparation and application of A-D-A type organic micromolecular photosensitizer Download PDF

Info

Publication number
CN116478126B
CN116478126B CN202310292719.6A CN202310292719A CN116478126B CN 116478126 B CN116478126 B CN 116478126B CN 202310292719 A CN202310292719 A CN 202310292719A CN 116478126 B CN116478126 B CN 116478126B
Authority
CN
China
Prior art keywords
photosensitizer
receptor
strong
donor
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202310292719.6A
Other languages
Chinese (zh)
Other versions
CN116478126A (en
Inventor
甄士杰
徐哲
李美静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guilin University of Technology
Original Assignee
Guilin University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilin University of Technology filed Critical Guilin University of Technology
Priority to CN202310292719.6A priority Critical patent/CN116478126B/en
Publication of CN116478126A publication Critical patent/CN116478126A/en
Application granted granted Critical
Publication of CN116478126B publication Critical patent/CN116478126B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention belongs to the field of biomedical materials, and discloses preparation and application of a strong A-D-A type organic micromolecular photosensitizer. The invention is based on a receptor-donor-receptor configuration, having the structure shown below: Wherein: ar is aromatic heterocycle and its derivative, X is hydrogen element or fluorine element or chlorine element. The invention builds strong receptor-donor-receptor and strong charge transfer state and simultaneously inhibits the intermolecular pi-pi stacking effect of molecules in the aggregation state by introducing groups such as strong electron-withdrawing cyano indenone, derivative and the like at two ends of donor triphenylamine or tetraphenyl ethylene and derivative, thereby endowing the material with AIE characteristics. In addition, heavy atoms such as fluorine atoms or chlorine atoms are introduced, so that the energy gap crossing of the excited singlet state to the triplet state is promoted to realize efficient active oxygen generation. Based on the high-efficiency fluorescence quantum efficiency and ROS production capability, the material provided by the invention has a good application prospect in fluorescence imaging-mediated tumor photodynamic therapy.

Description

Preparation and application of A-D-A type organic micromolecular photosensitizer
Technical Field
The invention belongs to the field of biomedical materials, and particularly relates to preparation and application of an A-D-A type organic micromolecular photosensitizer.
Background
The traditional photosensitizers mostly have planar structures and relatively poor water solubility, and are easy to cause dense pi-pi accumulation among molecules to cause excited state molecules to return to a ground state in a non-radiative transition mode of conversion, and the aggregated state not only can cause fluorescence quenching of the photosensitizers, but also can greatly reduce the photosensitizing efficiency of the photosensitizers. The discovery of the AIE phenomenon solves these problems well, and these AIE molecules not only have strong fluorescence in the aggregated state, but also have good photosensitizing efficiency. According to the perturbation theory, the method comprises the following steps, Enhancing spin-orbit coupling (SOC) or reducing the photosensitizer singlet (S 1) to singlet (T 1) bandgap difference (deltae ST) can facilitate intersystem crossing (ISC) of singlet (S 1) to singlet (T 1), Thereby enhancing the photosensitivity efficiency of the photosensitizer. Spin-orbit coupling is a function of electron spin and orbit magnetic quantum number, and the stronger the nuclear electropositivity, namely the heavier the atoms, the stronger the coupling effect of electron spin and orbit magnetic quantum number, so that connecting the photosensitizer with heavy atoms is the most direct way of promoting intersystem crossing and improving the photosensitizer efficiency. The difference in energy between S 1 and T 1 is simply due to the mutual exclusion of the two opposite spin-direction valence electrons in S 1 resulting in an energy above T 1, The mutual exclusion of electrons and the distance between two valence electrons are in a negative correlation, Separation of HOMO and LUMO in S 1 can effectively reduce the bandgap difference (Δe ST) from S 1 to T 1. The addition of electron-withdrawing groups to the molecular structure of the photosensitizer may promote the separation of the photosensitizer HOMO and LUMO, thereby reducing the energy gap difference from singlet S 1 to triplet T 1.
Disclosure of Invention
Aiming at the problems, the AIE material with high near infrared luminous efficiency, adjustable absorption and emission spectrum and good light stability is designed and synthesized, and the interference of self-absorption and autofluorescence of biological tissues is overcome. The preparation of the near infrared luminescent AIE material is realized based on the cyano-indenone skeleton. Meanwhile, the photodynamic efficiency is improved by a method of reducing the level difference of the singlet state and the triplet state, and the near-infrared AIE material with high luminous efficiency and high photodynamic activity is screened out.
In order to achieve the above purpose, the present invention provides the following technical solutions: A-D-A organic small molecule photosensitizer is prepared and application thereof, and the preparation method comprises the following steps:
In nitrogen atmosphere, adding an aldehyde group-containing strong electron donor compound and cyano-indidone into a reactor at a molar ratio of 1:3, adding chloroform as a solvent, adding a catalyst pyridine, stirring the mixture by a magnetic stirring device to dissolve the mixture, heating the mixture to 80 ℃ for reaction for 3 hours, decompressing and evaporating the solvent after the reaction is finished to obtain a crude product, and purifying the crude product by column chromatography to obtain the target compound.
The structure is I
Wherein X = fluorine or chlorine;
ar=an aromatic ring electron donating group, and is any one of the following groups.
The invention has the beneficial effects that:
1. The invention synthesizes a new photosensitizer material system with AIE performance to overcome the problem of the decrease of tumor treatment effect caused by the fluorescence aggregation quenching effect and tumor hypoxia of the existing photosensitizer.
2. The near infrared photosensitizer with AIE property provided by the invention has stronger total active oxygen generating capacity than commercial photosensitizer chlorin (Ce 6).
3. The near infrared photosensitizer with AIE property provided by the invention has the advantages of few synthesis steps, simple method and easily available raw materials.
4. The near infrared photosensitizer with AIE property provided by the invention can have good fluorescence imaging effect on in-vitro cells and living tumors; even under the condition of hypoxia, the composition can still have good killing performance on cancer cells; but also has high-efficiency cure to the living tumor of the mice.
Drawings
FIG. 1 is a normalized absorption spectrum of TPAPT-4F and 2TPAPT-4F in THF;
FIG. 2 is a graph showing the emission spectra of the obtained materials TPAPT-4F and 2TPAPT-4F in THF
FIG. 3 shows the total active oxygen generating capacity of TPAPT-4F and 2TPAPT-4F, and the photosensitizer Ce 6.
FIG. 4 (A) and FIG. 4 (C) are graphs showing the fluorescence spectra under different water contents, and the fluorescence intensities of TPAPT-4F and 2TPAPT-4F are significantly increased after gradually adding water to THF solution, FIG. 4 (B) and FIG. 4 (D) are graphs showing the relationship between I/I 0 of TPAPT-4F and 2TPAPT-4F and the water content of the solvent mixture
FIG. 5 is a mass spectrum of photosensitizer TPAPT-4F
FIG. 6 is a mass spectrum of photosensitizer 2TPAPT-4F
Detailed Description
The following technical solutions in the embodiments of the present invention will be clearly and completely described with reference to the accompanying drawings, so that those skilled in the art can better understand the advantages and features of the present invention, and thus the protection scope of the present invention is more clearly defined. The described embodiments of the present invention are intended to be only a few, but not all embodiments of the present invention, and all other embodiments that may be made by one of ordinary skill in the art without inventive faculty are intended to be within the scope of the present invention.
Example 1:
preparation of photosensitizer TPAPT-4F:
synthetic route for photosensitizer TPAPT-4F
Dibromotriphenylamine (0.4 g,0.99 mmol) (1), 5-aldehyde-2-thiopheneboronic acid (0.38 g,2.4 mmol), palladium acetate (0.012 g,0.05 mmol), X-Phos (0.04 g,0.08 mmol), potassium phosphate (1.72 g,7.9 mmol) were added to a mixture of 20mL tetrahydrofuran and water 1:1. After mixing and stirring uniformly, heating to 90 ℃ under the atmosphere of nitrogen, reacting for 12 hours, cooling to room temperature, and filtering the mixture to remove insoluble impurities. The mixture was then poured into water and extracted three times with dichloromethane. The combined organic layers were washed successively with saturated sodium bicarbonate and water, and then dried over anhydrous magnesium sulfate. After filtration, the solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography. Yellow solid (2) was obtained in 45.7% yield (357 mg). 0.2g of the product and 5, 6-difluoro-3- (dicyanomethylene) indigonone (0.226 g,0.98 mmol) were weighed, a few drops of pyridine was added as a catalyst, reacted for 4 hours at 70 ℃, cooled to room temperature, the solvent was evaporated under reduced pressure, the appropriate chloroform was added for dissolution, a large amount of methanol was added to precipitate a solid, and the solid was filtered to obtain a dark black solid (0.2 g) with a yield of 93.8%.
The structural characterization data of the resulting product are shown below:
1H NMR(400MHz,C6D6)δ7.35(s,1H),6.96(s,1H),5.32(s,1H),2.23(d,J=20.4Hz,4H),1.87–1.54(m,4H),1.37(s,6H),0.87(d,J=6.5Hz,1H),0.35(d,J=42.8Hz,5H).
Example 2:
preparation of photosensitizer 2TPAPT-4F
The synthetic route is as follows:
Synthetic route for photosensitizer 2TPAPT-4F
4-Bromotrianiline (3.24 g,10 mmol) iodine (2.53 g,10 mmol) periodic acid (0.05 g,0.2 mmol) was dissolved in 50mL absolute ethanol and heated to 80℃for 4h, the reaction was cooled to room temperature, the mixture was filtered and the product (2) was used directly in the next reaction. The product of the previous step (2.33 g,3.8 mmol), diphenylamine (1.71 g,10 mmol), cuprous iodide (0.046 g,0.2 mmol), 1.10-phenanthroline (0.043 g,0.2 mmol) and potassium hydroxide (1.71 g,30 mmol) were weighed and reacted in 50mL toluene solution at 120℃for 36h. After cooling to room temperature, the mixture was filtered to remove insoluble impurities. Purification by column chromatography gave 1.2g of the desired product (3). The above product (0.6 g,0.97 mmol), 5-aldehyde-2-thiopheneboronic acid (0.34 g,2.2 mmol), tetrakis (triphenylphosphine) palladium (0.11 g,0.097 mmol), potassium carbonate (0.5 g,3.64 mmol) were weighed into 15mL THF and 15mL water, reacted under nitrogen atmosphere for 24h, cooled to room temperature, and the mixture was filtered to remove insoluble impurities. Purification by column chromatography gave 0.5g of the desired product (4) in 53% yield. 0.2g of the product and 5, 6-difluoro-3- (dicyanomethylene) indigonone (0.18 g,0.79 mmol) were weighed, a few drops of pyridine were added as a catalyst, reacted for 4 hours at 70 ℃, cooled to room temperature, the solvent was evaporated under reduced pressure, the appropriate chloroform was added for dissolution, a large amount of methanol was added to precipitate a solid, and the solid was filtered to obtain a dark black solid (0.2 g) with a yield of 78.9%.
The structural characterization data of the resulting product are shown below:
1H NMR(400MHz,CD2Cl2)δ5.10(d,J=22.3Hz,1H),2.04(s,3H),1.67(s,3H),1.53(s,13H),1.26(s,8H),0.87(d,J=4.1Hz,4H).
Example 3:
Characterization of absorption spectra of A-D-A type photosensitizers (TPAPT-4F and 2 TPAPT-4F)
FIG. 1 is a graph of absorption spectra in THF of materials TPAPT-4F and 2TPAPT-4F obtained in examples 1 and 2, wherein the maximum absorption spectrum of TPAPT-4F in THF solution is 616nm, and the maximum absorption wavelength of 2TPAPT-4F is 640nm, showing that the absorption spectrum is significantly red shifted by enhancing the electron donating ability of electron donating groups, promoting the charge transfer in excited state molecules.
Example 4:
characterization of the emission spectra of type A-D-A photosensitizers (TPAPT-4F and 2 TPAPT-4F)
FIG. 2 is a graph of emission spectra in THF of materials TPAPT-4F and 2TPAPT-4F obtained in examples 1 and 2, with a maximum emission spectrum of TPAPT-4F in THF solution of 910nm and a maximum emission spectrum of 2TPAPT-4F of 977nm, indicating that the strong electron withdrawing effect of fluorine can impart ionic character to the C-F bond, which makes the C-F bond highly polarized, enhances electrostatic interactions between adjacent molecules, and promotes red shift of emission wavelength.
Example 5:
ROS-forming ability of A-D-A type photosensitizers
FIG. 3 is a graph comparing the total active oxygen generating capacity of TPAPT-4F and 2TPAPT-4F, and the photosensitizer Ce 6. The active oxygen probe DCFH, after binding to active oxygen, produced green fluorescence at 522 nm. The molecular concentration was 10. Mu.M in the test, and the optical density was 0.3W/cm -2 by irradiation with a 660nm laser. The results indicate that the TPAPT-4F and 2TPAPT-4F molecules are capable of producing higher fluorescence enhancement factors than Ce6, indicating that the TPAPT-4F and 2TPAPT-4F molecules have a greater ROS production capacity.
Example 6
FIGS. 4 (A) and 4 (C) are graphs of fluorescence spectra under different water content conditions, with the fluorescence intensities of TPAPT-4F and 2TPAPT-4F significantly increasing after gradual addition of water to the THF solution, and FIGS. 4 (B) and 4 (D) are graphs of I/I 0 of TPAPT-4F and 2TPAPT-4F versus water content of the solvent mixture, with PL emissions of TPAPT-4F and 2TPAPT-4F quenched before the critical point (0% water fraction). After the critical point, the fluorescence intensity increased with the addition of water, indicating its aggregation-induced emission characteristics.

Claims (3)

1. An A-D-A type organic small molecule photosensitizer is characterized in that:
wherein X = fluorine or chlorine; ar=aromatic ring electron donating group, any one of the following groups:
2. the use of a class of a-D-a type small organic molecule photosensitizers as claimed in claim 1 for the preparation of imaging agents for cancer cells.
3. The use of a class of small organic molecule photosensitizers as claimed in claim 1 for the preparation of photodynamic therapeutic agents for tumors.
CN202310292719.6A 2023-03-23 2023-03-23 Preparation and application of A-D-A type organic micromolecular photosensitizer Active CN116478126B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310292719.6A CN116478126B (en) 2023-03-23 2023-03-23 Preparation and application of A-D-A type organic micromolecular photosensitizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310292719.6A CN116478126B (en) 2023-03-23 2023-03-23 Preparation and application of A-D-A type organic micromolecular photosensitizer

Publications (2)

Publication Number Publication Date
CN116478126A CN116478126A (en) 2023-07-25
CN116478126B true CN116478126B (en) 2024-10-15

Family

ID=87214651

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310292719.6A Active CN116478126B (en) 2023-03-23 2023-03-23 Preparation and application of A-D-A type organic micromolecular photosensitizer

Country Status (1)

Country Link
CN (1) CN116478126B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299408A (en) * 2018-01-23 2018-07-20 西安近代化学研究所 Condensed ring A-D-A type conjugated molecules based on carbazole and preparation method thereof
CN113861392A (en) * 2021-10-13 2021-12-31 福州大学 Fluorenyl cyano indanone non-conjugated polymer receptor and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230276641A1 (en) * 2020-07-31 2023-08-31 Sony Group Corporation Photoelectric conversion element and imaging device
GB2602025A (en) * 2020-12-15 2022-06-22 Sumitomo Chemical Co Compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299408A (en) * 2018-01-23 2018-07-20 西安近代化学研究所 Condensed ring A-D-A type conjugated molecules based on carbazole and preparation method thereof
CN113861392A (en) * 2021-10-13 2021-12-31 福州大学 Fluorenyl cyano indanone non-conjugated polymer receptor and preparation method thereof

Also Published As

Publication number Publication date
CN116478126A (en) 2023-07-25

Similar Documents

Publication Publication Date Title
Ünlü et al. Preparation of BODIPY-fullerene and monostyryl BODIPY-fullerene dyads as heavy atom free singlet oxygen generators
CN112341452A (en) Compound, preparation method thereof and triplet-triplet annihilation up-conversion system
Sarıkaya et al. Novel BODIPY-Cyclotriphosphazene-Fullerene triads: Synthesis, characterization and singlet oxygen generation efficiency
CN107434787A (en) A kind of preparation, structure and the photoluminescent property of benzimidazole perchlorate
CN116478126B (en) Preparation and application of A-D-A type organic micromolecular photosensitizer
CN112358493B (en) Micromolecular photothermal reagent based on boron-fluorine complex and preparation method and application thereof
Drouet et al. Fluorenyl dendrimer porphyrins: synthesis and photophysical properties
CN115819281B (en) Cyano-substituted p-phenylene ethylene derivative, preparation method and application
CN112218855B (en) NIR-II emissive luminophores
CN112079776A (en) Light-induced crystallized isoquinoline salt compound, preparation method and application thereof, and preparation method of nanocrystal
CN112979527B (en) Halogenimide material with long-wavelength room-temperature phosphorescence emission and application
CN105969336B (en) Triplet-triplet annihilation up-conversion luminescent material based on dendritic polymer structure
CN113024586B (en) Cell membrane targeted BODIPY type organic photosensitizer and application thereof
CN110511236B (en) Fluoroglycopyrrolate photosensitizer and preparation method and application thereof
CN113501836A (en) Star BODIPY near-infrared fluorescent dye and preparation method thereof
CN113461698A (en) Trimeric indenyl dicumarol-corrole triplet photosensitizer and preparation method and application thereof
CN115737809B (en) Preparation of nitrogen heteroatom-containing photosensitizer and tumor photodynamic therapy thereof
CN114249758A (en) Dimer based on five-membered aromatic heterocyclic BODIPY and preparation method thereof
CN111961067A (en) Azo-based dicarbole derivative and preparation method thereof
CN114671882B (en) Tri-indenyl bridged zinc porphyrin-coumarin star-type triplet photosensitizer and preparation method and application thereof
CN117865950A (en) Synthesis and application of strong D-A type organic near infrared two-region luminescent material
CN115490631B (en) Near-infrared thermal activation delayed fluorescence luminescent material based on dicyanophenalene and application thereof
CN115109027B (en) Degradable fluorescent molecule for photodynamic therapy, preparation method and application
CN113480550B (en) Bishydroxycoumarin conjugated porphyrin derivative and preparation method thereof
CN112110931B (en) Axial coordination composite material with two-photon absorption characteristic

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant